[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Foscarnet Market Report 2016

December 2016 | 111 pages | ID: UFB839F03C7EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Foscarnet

Revenue, means the sales value of Foscarnet

This report studies sales (consumption) of Foscarnet in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Agenus, Inc. (US)
  • AiCuris GmbH & Co.KG (Germany)
  • Astellas Pharma, Inc. (Japan)
  • Clinigen Group (UK)
  • Cytogenix, Inc. (US)
  • Genocea Biosciences (US)
  • GlaxoSmithKline Plc. (UK)
  • Lumavita AG (Switzerland)
  • NanoBio Corporation (US)
  • NanoViricides, Inc. (US)
  • Novartis International AG (Switzerland)
  • Sanofi (France)
  • Starpharma Holdings Limited (Australia)
  • Vical (US)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Foscarnet in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Foscarnet Market Report 2016

1 FOSCARNET OVERVIEW

1.1 Product Overview and Scope of Foscarnet
1.2 Classification of Foscarnet
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Foscarnet
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Foscarnet (2011-2021)
  1.4.1 United States Foscarnet Sales and Growth Rate (2011-2021)
  1.4.2 United States Foscarnet Revenue and Growth Rate (2011-2021)

2 UNITED STATES FOSCARNET COMPETITION BY MANUFACTURERS

2.1 United States Foscarnet Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Foscarnet Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Foscarnet Average Price by Manufactures (2015 and 2016)
2.4 Foscarnet Market Competitive Situation and Trends
  2.4.1 Foscarnet Market Concentration Rate
  2.4.2 Foscarnet Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES FOSCARNET SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Foscarnet Sales and Market Share by Type (2011-2016)
3.2 United States Foscarnet Revenue and Market Share by Type (2011-2016)
3.3 United States Foscarnet Price by Type (2011-2016)
3.4 United States Foscarnet Sales Growth Rate by Type (2011-2016)

4 UNITED STATES FOSCARNET SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Foscarnet Sales and Market Share by Application (2011-2016)
4.2 United States Foscarnet Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES FOSCARNET MANUFACTURERS PROFILES/ANALYSIS

5.1 Agenus, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Foscarnet Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Agenus, Inc. (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AiCuris GmbH & Co.KG (Germany)
  5.2.2 Foscarnet Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AiCuris GmbH & Co.KG (Germany) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Astellas Pharma, Inc. (Japan)
  5.3.2 Foscarnet Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Astellas Pharma, Inc. (Japan) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Clinigen Group (UK)
  5.4.2 Foscarnet Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Clinigen Group (UK) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Cytogenix, Inc. (US)
  5.5.2 Foscarnet Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Cytogenix, Inc. (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Genocea Biosciences (US)
  5.6.2 Foscarnet Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Genocea Biosciences (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 GlaxoSmithKline Plc. (UK)
  5.7.2 Foscarnet Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 GlaxoSmithKline Plc. (UK) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Lumavita AG (Switzerland)
  5.8.2 Foscarnet Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Lumavita AG (Switzerland) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 NanoBio Corporation (US)
  5.9.2 Foscarnet Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 NanoBio Corporation (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 NanoViricides, Inc. (US)
  5.10.2 Foscarnet Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 NanoViricides, Inc. (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Novartis International AG (Switzerland)
5.12 Sanofi (France)
5.13 Starpharma Holdings Limited (Australia)
5.14 Vical (US)

6 FOSCARNET MANUFACTURING COST ANALYSIS

6.1 Foscarnet Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Foscarnet

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Foscarnet Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Foscarnet Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES FOSCARNET MARKET FORECAST (2016-2021)

10.1 United States Foscarnet Sales, Revenue Forecast (2016-2021)
10.2 United States Foscarnet Sales Forecast by Type (2016-2021)
10.3 United States Foscarnet Sales Forecast by Application (2016-2021)
10.4 Foscarnet Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Foscarnet
Table Classification of Foscarnet
Figure United States Sales Market Share of Foscarnet by Type in 2015
Table Application of Foscarnet
Figure United States Sales Market Share of Foscarnet by Application in 2015
Figure United States Foscarnet Sales and Growth Rate (2011-2021)
Figure United States Foscarnet Revenue and Growth Rate (2011-2021)
Table United States Foscarnet Sales of Key Manufacturers (2015 and 2016)
Table United States Foscarnet Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Foscarnet Sales Share by Manufacturers
Figure 2016 Foscarnet Sales Share by Manufacturers
Table United States Foscarnet Revenue by Manufacturers (2015 and 2016)
Table United States Foscarnet Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Foscarnet Revenue Share by Manufacturers
Table 2016 United States Foscarnet Revenue Share by Manufacturers
Table United States Market Foscarnet Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Foscarnet Average Price of Key Manufacturers in 2015
Figure Foscarnet Market Share of Top 3 Manufacturers
Figure Foscarnet Market Share of Top 5 Manufacturers
Table United States Foscarnet Sales by Type (2011-2016)
Table United States Foscarnet Sales Share by Type (2011-2016)
Figure United States Foscarnet Sales Market Share by Type in 2015
Table United States Foscarnet Revenue and Market Share by Type (2011-2016)
Table United States Foscarnet Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Foscarnet by Type (2011-2016)
Table United States Foscarnet Price by Type (2011-2016)
Figure United States Foscarnet Sales Growth Rate by Type (2011-2016)
Table United States Foscarnet Sales by Application (2011-2016)
Table United States Foscarnet Sales Market Share by Application (2011-2016)
Figure United States Foscarnet Sales Market Share by Application in 2015
Table United States Foscarnet Sales Growth Rate by Application (2011-2016)
Figure United States Foscarnet Sales Growth Rate by Application (2011-2016)
Table Agenus, Inc. (US) Basic Information List
Table Agenus, Inc. (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Agenus, Inc. (US) Foscarnet Sales Market Share (2011-2016)
Table AiCuris GmbH & Co.KG (Germany) Basic Information List
Table AiCuris GmbH & Co.KG (Germany) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table AiCuris GmbH & Co.KG (Germany) Foscarnet Sales Market Share (2011-2016)
Table Astellas Pharma, Inc. (Japan) Basic Information List
Table Astellas Pharma, Inc. (Japan) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma, Inc. (Japan) Foscarnet Sales Market Share (2011-2016)
Table Clinigen Group (UK) Basic Information List
Table Clinigen Group (UK) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Clinigen Group (UK) Foscarnet Sales Market Share (2011-2016)
Table Cytogenix, Inc. (US) Basic Information List
Table Cytogenix, Inc. (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytogenix, Inc. (US) Foscarnet Sales Market Share (2011-2016)
Table Genocea Biosciences (US) Basic Information List
Table Genocea Biosciences (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genocea Biosciences (US) Foscarnet Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Foscarnet Sales Market Share (2011-2016)
Table Lumavita AG (Switzerland) Basic Information List
Table Lumavita AG (Switzerland) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lumavita AG (Switzerland) Foscarnet Sales Market Share (2011-2016)
Table NanoBio Corporation (US) Basic Information List
Table NanoBio Corporation (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table NanoBio Corporation (US) Foscarnet Sales Market Share (2011-2016)
Table NanoViricides, Inc. (US) Basic Information List
Table NanoViricides, Inc. (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table NanoViricides, Inc. (US) Foscarnet Sales Market Share (2011-2016)
Table Novartis International AG (Switzerland) Basic Information List
Table Novartis International AG (Switzerland) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis International AG (Switzerland) Foscarnet Sales Market Share (2011-2016)
Table Sanofi (France) Basic Information List
Table Sanofi (France) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi (France) Foscarnet Sales Market Share (2011-2016)
Table Starpharma Holdings Limited (Australia) Basic Information List
Table Starpharma Holdings Limited (Australia) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Starpharma Holdings Limited (Australia) Foscarnet Sales Market Share (2011-2016)
Table Vical (US) Basic Information List
Table Vical (US) Foscarnet Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical (US) Foscarnet Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Foscarnet
Figure Manufacturing Process Analysis of Foscarnet
Figure Foscarnet Industrial Chain Analysis
Table Raw Materials Sources of Foscarnet Major Manufacturers in 2015
Table Major Buyers of Foscarnet
Table Distributors/Traders List
Figure United States Foscarnet Production and Growth Rate Forecast (2016-2021)
Figure United States Foscarnet Revenue and Growth Rate Forecast (2016-2021)
Table United States Foscarnet Production Forecast by Type (2016-2021)
Table United States Foscarnet Consumption Forecast by Application (2016-2021)


More Publications